Repligen Corporation has acquired 908 Devices' desktop portfolio, which includes four analytical devices for bioprocessing applications, for $70 million in cash. This acquisition enhances Repligen's ...
Portfolio includes PAT devices for real-time process monitoring, control and analysis Repligen Corporation (Nasdaq: RGEN), a life sciences company focused on bioprocessing technology leadership, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback